JT
RXRX icon

Jupiter Topco’s Recursion Pharmaceuticals RXRX Stock Holding History

Jupiter Topco’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Buy
+220,309
New +$733K ﹤0.01% 1877

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Jupiter Topco's RXRX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 220,309 shares worth $810K. The stake represents ﹤0.01% of the portfolio and ranks #1877 among its holdings.

320 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Jupiter Topco held 220,309 shares of Recursion Pharmaceuticals worth $810K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1877 holding.
  • 320 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.